ArticleCancer research2025

Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.

Ziwei Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.